Inventor · disambiguated record
Meihua Mike Tu
Also filed as: TU MEIHUA · TU MEIHUA M · TU MEIHUA MIKE
19 granted patents·11 pending applications·50 citations·filing 2009–2024
92Inventor score
Top patents by PatentIndex Score
30 records- 0196US9809579B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2016·Granted Nov 7, 2017·26 cites·26 claims
- 0291US10174007B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2017·Granted Jan 8, 2019·8 cites·12 claims
- 0385US10988463B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2020·Granted Apr 27, 2021·1 cites·8 claims
- 0483US10787438B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2020·Granted Sep 29, 2020·1 cites·24 claims
- 0580US8889730B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Nov 18, 2014·5 cites·5 claims
- 0679US7977367B2Substituted imidazole propanamide glucokinase activatorsPFIZER·Filed 2009·Granted Jul 12, 2011·3 cites·15 claims
- 0778US8507533B2Glucagon receptor modulatorsASPNES GARY ERIK·Filed 2012·Granted Aug 13, 2013·3 cites·5 claims
- 0876US11634410B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2021·Granted Apr 25, 2023·0 cites·18 claims
- 0972US9056834B2Glucagon receptor modulatorsPFIZER·Filed 2014·Granted Jun 16, 2015·1 cites·10 claims
- 1072US8859591B2Glucagon receptor modulatorsPFIZER·Filed 2013·Granted Oct 14, 2014·1 cites·18 claims
- 1169US9394285B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Jul 19, 2016·1 cites·6 claims
- 1266US9073871B2Glucagon receptor modulatorsPFIZER·Filed 2014·Granted Jul 7, 2015·0 cites·2 claims
- 1365US2024336572A1Substituted indazole propionic acid derivative compounds and uses thereofPFIZER·Filed 2024·Application pending·0 cites
- 1465US2019106412A1Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2018·Application pending·0 cites
- 1562US9139538B2Quinolinyl glucagon receptor modulatorsPFIZER·Filed 2014·Granted Sep 22, 2015·0 cites·8 claims
- 1662US8933104B2Glucagon receptor modulatorsPFIZER·Filed 2014·Granted Jan 13, 2015·0 cites·10 claims
- 1762US2024182468A1Compounds for the activation of ampkPFIZER·Filed 2023·Application pending·0 cites
- 1858US9452999B2Glucagon receptor modulatorsPFIZER·Filed 2015·Granted Sep 27, 2016·0 cites·12 claims
- 1957US2013165452A1Substituted HeteroarylsPFIZER·Filed 2013·Application pending·0 cites
- 2057US2016362392A1Glucagon receptor modulatorsPFIZER·Filed 2016·Application pending·0 cites
- 2156US8389552B2(S)-6-(2-(4-(cyclobutylsulfonyl)-1H-imidazol-1-yl)-3-cyclopentylpropanamido)nicotinic acid useful as a glucokinase activatorPFEFFERKORN JEFFREY ALLEN·Filed 2012·Granted Mar 5, 2013·0 cites·3 claims
- 2255US2022184041A1(AZA)Benzothiazolyl Substituted Pyrazole CompoundsPFIZER·Filed 2021·Application pending·0 cites
- 2354US8809342B2Glucagon receptor modulatorsASPNES GARY ERIK·Filed 2011·Granted Aug 19, 2014·0 cites·8 claims
- 2451US8329920B2Substituted imidazoles useful for treating type II diabetesBENBOW JOHN WILLIAM·Filed 2011·Granted Dec 11, 2012·0 cites·10 claims
- 2551US2015038484A1Indole and indazole compounds that activate ampkPFIZER·Filed 2014·Application pending·0 cites
- 2651US2015266861A1Glucagon Receptor ModulatorsPFIZER·Filed 2015·Application pending·0 cites
- 2750US8927577B2Quinolinyl glucagon receptor modulatorsDIDIUK MARY·Filed 2012·Granted Jan 6, 2015·0 cites·13 claims
- 2849US2011130365A1Fluorinated HeteroarylsBENBOW JOHN W·Filed 2009·Application pending·0 cites
- 2947US2015353508A1Quinolinyl glucagon receptor modulatorsPFIZER·Filed 2015·Application pending·0 cites
- 3031US2011319379A1Substituted Indazole Amides And Their Use As Glucokinase ActivatorsCORBETT JEFFREY W·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Meihua Mike Tu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →